IL2RA and pericarditis: Given her elevated IL-2R, fever with pericarditis and serositis, and family history of successful treatment with IL-1 blockade, she was started on canakinumab, but due to breakthrough pericarditis, she was transitioned to rilonacept as it is specific for recurrent pericarditis, which led to symptom resolution.